Exclusively focused on representing plaintiffs, especially in mass tort litigation, Eric Chaffin prides himself on providing unsurpassed professional legal services in pursuit of the specific goals of his clients and their families.
Supposed advances in birth control medications have led to increased litigation over the past several years. It started when patients complained of side effects related to oral contraceptives…
According to a recent article in USA Today, consumers are pushing for a ban on firepots. These decorative candle-like ceramic products create an atmospheric or insect-repelling flame through the…
In the light of thousands of reports of injuries from metal-on-metal (MoM) hip implants, and the increasing number of lawsuits filed against such companies as DePuy Orthopaedics and Zimmer, Inc.,…
In the wake of thousands of lawsuits against manufacturers of metal-on-metal hip and knee implants, the FDA has proposed a new identification system that may make it easier for the agency to…
On April 17, 2012, the U.S. Judicial Panel on Multidistrict Litigation (JPML) ordered the consolidation of up to 100 Zoloft lawsuits concerning claims about the antidepressant and birth defects….
In a lawsuit filed June 6, 2012, 38 plaintiffs claim that the antidepressant Zoloft (sertraline) caused their newborn children to suffer from birth defects. Like other plaintiffs who have filed…
On June 9, 2010, the U.S. Judicial Panel on Multidistrict Litigation established the Zimmer Durom Cup hip implant MDL, consolidating all federal cases into one court in the District of New…
According to recently released court documents, Johnson & Johnson (J&J) continued to sell the Gynecare Prolift vaginal mesh implant after the FDA told the company to halt sales in August…
In June 2011, the FDA released a safety communication warning diabetes patients and their physicians about a potential link between the drug Actos (pioglitazone) and bladder cancer. At the time,…
You were wrong if you thought you heard the last of exploding firepots last year when the U.S. Consumer Product Safety Commission (CPSC), along with nine manufacturers, announced a national gel…
During the last week of June 2012, the FDA convened a two-day advisory panel consisting of 18 members to meet and discuss the safety of metal-on-metal (MoM) hip implants. The panel was tasked…
During the recent FDA panel two-day meeting on metal-on-metal implants, the 18 experts evaluated safety issues associated with such implants as the DePuy ASR, DePuy Pinnacle, Zimmer Durom Cup,…
